Format

Send to

Choose Destination
J Cell Biochem. 2006 Jan 1;97(1):18-32.

Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.

Author information

1
Department of Surgery/Urology, University of Kentucky Medical Center, Lexington, KY, USA.

Abstract

The ability of a tumor cell population to grow exponentially represents an imbalance between cellular proliferation and cellular attrition. There is an overwhelming body of evidence suggesting the ability of tumor cells to avoid programmed cellular attrition, or apoptosis, is a major molecular force driving the progression of human tumors. Apoptotic evasion represents one of the true hallmarks of cancer and appears to be a vital component in the immunogenic, chemotherapeutic, and radiotherapeutic resistance that characterizes the most aggressive of human cancers [Hanahan and Weinberg, 2000]. The challenges in the development of effective treatment modalities for advanced prostate cancer represent a classic paradigm of the functional significance of anti-apoptotic pathways in the development of therapeutic resistance.

PMID:
16216007
PMCID:
PMC2274918
DOI:
10.1002/jcb.20634
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center